CorMedix Inc. (NASDAQ: CRMD)
$4.99
+0.0900 ( +1.84% ) 583.4K
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.
Market Data
Open
$4.99
Previous close
$4.90
Volume
583.4K
Market cap
$274.80M
Day range
$4.88 - $5.03
52 week range
$2.57 - $7.00
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-k | Annual reports | 71 | Mar 12, 2024 |
8-k | 8K-related | 16 | Mar 12, 2024 |
8-k | 8K-related | 16 | Jan 30, 2024 |
4/a | Other | 1 | Jan 18, 2024 |
4 | Insider transactions | 1 | Jan 17, 2024 |
4 | Insider transactions | 1 | Jan 17, 2024 |
4 | Insider transactions | 1 | Jan 17, 2024 |
4 | Insider transactions | 1 | Jan 17, 2024 |
4 | Insider transactions | 1 | Dec 18, 2023 |
8-k | 8K-related | 12 | Dec 15, 2023 |